|
KZIA Kazia Therapeutics Ltd 1075880 |
| Income Statement |
|
Net Income
|
d121422d6k
|
-26,778,000 |
| Balance Sheet |
|
Current Assets
|
6,145,000 |
|
Assets
|
21,585,000 |
|
Current Liabilities
|
25,797,000 |
|
Liabilities
|
21,585,000 |
|
Shares Out
|
11,335,992 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-9,581,000 |
| Market Analysis |
Market Cap
|
123,743,185 |
|
Price
|
11.53 |
|
BVPS
|
3.49 |
|
PB
|
0.28 |
|
EPS
|
-6.50 |
|
PS
|
0.10 |
|
FCF
|
-9,581,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KZIA documents filed with the SEC.
KZIA Filings
Clear
